<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="36672">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01717521</url>
  </required_header>
  <id_info>
    <org_study_id>42398</org_study_id>
    <nct_id>NCT01717521</nct_id>
  </id_info>
  <brief_title>Effects of IV Administration of Ketamine on the Analgesia Nociception Index (ANI) Measured With the PhysioDoloris</brief_title>
  <official_title>The Effects of Intravenous Administration of Ketamine on the Analgesia Nociception Index (ANI) Measured With the PhysioDoloris Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Washington</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Researchers at the UW are doing this study to find out if a commonly used anesthetic affects
      patients Analgesia Nociception Index (level of pain relief) during abdominal hysterectomy
      under general anesthesia.

      The investigators will administer routine anesthesia care including Ketamine, a commonly
      used anesthetic, during the patients surgery.  During the patients surgery, the
      investigators will monitor the patients level of pain relief using the PhysioDoloris
      monitor, which monitors the routinely used EKG monitor.  Though not yet FDA approved, the
      PhysioDoloris is completely non-invasive and collects data from the EKG monitor.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Analgesia Nociception Index</measure>
    <time_frame>15-20 minutes during surgery</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>A single dimensionless number, which is a measurement for analgesia</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">20</enrollment>
  <condition>Abdominal Gynecological Surgeries</condition>
  <arm_group>
    <arm_group_label>Cases</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Women undergoing gynecological/abdominal surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA status I, II, or III

          -  18 years or older

          -  Receiving GA with uncomplicated routine intubation

          -  Ability to provide informed consent

          -  English-speaking

        Exclusion Criteria:

          -  Presence of coronary artery disease, cardiac arrhythmias, or ketamine allergy

          -  Patient refusal

          -  History of substance abuse

          -  Patients taking psychotropic and/or opiate drugs

          -  Having a history of psychiatric diseases or psychological problems
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 15, 2013</lastchanged_date>
  <firstreceived_date>October 10, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Washington</investigator_affiliation>
    <investigator_full_name>Laurent Bollag</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>hysterectomy</keyword>
  <keyword>gynecological abdominal surgery</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
